dipivefrin and latanoprost

dipivefrin has been researched along with latanoprost in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's3 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Alm, A; Greve, E; Hoyng, PF; Rulo, A; Watson, P1
Alm, A; Mäepea, O; Widengård, I1
Fong, JC; Hong, SJ; Wang, HZ; Wu, KY1
Călugăru, D; Călugăru, M1

Reviews

2 review(s) available for dipivefrin and latanoprost

ArticleYear
The additive intraocular pressure-lowering effect of latanoprost in combined therapy with other ocular hypotensive agents.
    Survey of ophthalmology, 1997, Volume: 41 Suppl 2

    Topics: Acetazolamide; Adrenergic Agonists; Adrenergic beta-Antagonists; Animals; Carbonic Anhydrase Inhibitors; Drug Therapy, Combination; Epinephrine; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Muscarinic Agonists; Ophthalmic Solutions; Pilocarpine; Prostaglandins F, Synthetic; Timolol

1997
[Latanoprost topical ophthalmic combinations].
    Oftalmologia (Bucharest, Romania : 1990), 2004, Volume: 48, Issue:4

    Topics: Acetazolamide; Administration, Topical; Antihypertensive Agents; Brimonidine Tartrate; Dinoprost; Drug Combinations; Drug Therapy, Combination; Epinephrine; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Ophthalmic Solutions; Pilocarpine; Prostaglandins F, Synthetic; Quinoxalines; Timolol

2004

Trials

1 trial(s) available for dipivefrin and latanoprost

ArticleYear
Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeability.
    The British journal of ophthalmology, 1998, Volume: 82, Issue:4

    Topics: Adrenergic Agonists; Aged; Blood-Aqueous Barrier; Conjunctival Diseases; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Epinephrine; Female; Glaucoma, Open-Angle; Humans; Hyperemia; Intraocular Pressure; Latanoprost; Male; Middle Aged; Ocular Hypertension; Permeability; Prostaglandins F, Synthetic

1998

Other Studies

3 other study(ies) available for dipivefrin and latanoprost

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
A topical prostaglandin for glaucoma.
    The Medical letter on drugs and therapeutics, 1996, Nov-08, Volume: 38, Issue:987

    Topics: Administration, Topical; Adrenergic Agents; Adrenergic beta-Antagonists; Carbonic Anhydrase Inhibitors; Cholinergic Agents; Clinical Trials as Topic; Drug Tolerance; Epinephrine; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Multicenter Studies as Topic; Parasympathomimetics; Pilocarpine; Prostaglandins F, Synthetic; Timolol

1996
Effects of commercial antiglaucoma drugs to glutamate-induced [Ca2+)]i increase in cultured neuroblastoma cells.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2003, Volume: 19, Issue:3

    Topics: Animals; Antihypertensive Agents; Betaxolol; Brimonidine Tartrate; Calcium; Carteolol; Cell Death; Dose-Response Relationship, Drug; Epinephrine; Glaucoma; Glutamic Acid; Latanoprost; Mice; Neuroblastoma; Neurons; Neuroprotective Agents; Pilocarpine; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiazines; Thiophenes; Timolol; Tumor Cells, Cultured

2003